Royal Society of Chemistry, RSC Chemical Biology, 4(2), p. 1206-1220, 2021
DOI: 10.1039/d1cb00104c
Full text: Download
LRG1 is present abundantly in the microenvironment of many tumours. LRG1 targeting through the reported non-internalising ADC presents a novel and effective proof-of-concept en route to improving the efficacy of cancer therapeutics.